We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is a Beta Amyloid?

By Emma Lloyd
Updated May 23, 2024
Our promise to you
InfoBloom is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At InfoBloom, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

The beta amyloid protein is a large peptide containing between 39 and 43 amino acids. This peptide chain is thought to play a major role in the development of Alzheimer’s disease. The plaques which develop in the brains of people with Alzheimer’s are composed primarily of the beta amyloid peptide. This peptide may also play a role in the development of other neurological diseases such as Lewy body dementia.

Beta amyloid plaques are formed primarily from a peptide that is 42 amino acids long. The more common form of the peptide has only 40 amino acids, but the 42AA peptide has a greater tendency to form plaques. The plaques form because the protein is fibrillogenic, meaning that it has a tendency to clump together with other like proteins to form fibrous structures. These structures are the plaques which progressively inhibit normal brain function in people with Alzheimer’s disease.

Research suggests that the plaques cause dementia because these peptide fiber clumps attach themselves to neurons in the brain. Once attached, the fibers prevent the neurons from receiving signals from other cells in the brain. The affected neurons cannot function or communicate with other brain cells, and die as a result.

Alzheimer’s is partially genetically inherited, a trait which is associated with the tendency to produce beta amyloid peptides that are 42 amino acids in length. When an individual has one copy of the gene which produces the 42AA peptide, he or she has an increased risk of developing Alzheimer’s disease. A person with two copies of this gene is at high risk of developing early-onset Alzeimer’s.

Based on this knowledge of how the protein interacts to form plaques, researchers have come up with several ideas which are under investigation as potential therapies to treat Alzheimer’s disease. One of these is an enzyme called a beta-secretase inhibitor. This enzyme may be able to block cleavage of the amyloid protein into the 42AA form which is most strongly associated with the development of Alzheimer’s. A related idea is a gamma-secretase enzyme, which prevents formation of the 42AA peptide at another point in the production cycle.

Another approach to treat Alzheimer’s is the development of a beta amyloid antibody which can recognize and bind to the 42AA peptide. These antibodies may be able to bind to the peptide and prevent it from forming plaques. In addition, the antibody can help promote the destruction of the peptide, as the immune system will destroy the antibody-peptide complexes that form.

InfoBloom is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.

Related Articles

Discussion Comments
By anon280018 — On Jul 15, 2012

Are beta amyloid peptides also responsible for giving after-stroke aphasia? Is there any connection between Alzheimer's and aphasia? Is there any remedy whatsoever for aphasia? -- Firoz

InfoBloom, in your inbox

Our latest articles, guides, and more, delivered daily.

InfoBloom, in your inbox

Our latest articles, guides, and more, delivered daily.